Voyageur Pharmaceuticals launches contrast media product line following successful clinical results

  • Voyageur Pharmaceuticals Ltd (TSX-V:VM, OTC:VYYRF) announced that it has begun the market introduction of its new line of barium contrast media products in Canada and select international markets that accept Health Canada standards. The company is targeting jurisdictions aligned with Health Canada standards for initial distribution and is now providing product samples to diagnostic centers for evaluation.